Uric acid, rasburicase-8290

Test info

  
Uric acid, rasburicase
  
8290
  
LAB8290
  
UAR

Specimen

  
Lithium heparin (Li hep) plasma
  
  
1.0 mL
  
0.2 mL
  

The following special sample handling procedure must be followed to avoid ex vivo uric acid degradation:

  • Uric acid must be collected in heparinized plasma tubes
  • Immediatley following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting
  • Samples must be immediately immersed in an ice water bath
  

Centrifuge at 3,000 - 3,200 RPM for 5 minutes.

Samples are to be run immediately after centrifugation or the tube must be placed in an ice water bath and analyzed for uric acid within four (4) hours of collection.

  

Lt green plasma separator (PST)

  
Serum
  

Refrigerated/on ice - 4 hours

Performance

  
AHL - Chemistry: C
  
Daily
  
1 day
  

Enzymatic Colorimetric assay

Clinical and Interpretive info

  

Roche:

Males 3.4 - 7.0 mg/dl
Females 2.4 - 5.7 mg/dl
  

Rasburicase is a recombinant urate-oxidase enzyme approved for use by the FDA in patients who are at risk of developing tumor lysis syndrome or for the management of elevated uric acid levels. Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite allantoin. At room temperature, ELITEK causes enzymatic degradation of the uric acid in blood, plasma, and serum samples potentially resulting in spuriously low plasma uric acid assay readings.

Billing

  
84550

Tracking

  
12/19/2017
  
03/06/2023
  
03/02/2022